Publications

Balancing IL-17–mediated protection and IFN-γ–driven pathology at mucocutaneous barriers

 457
Balancing IL-17–mediated protection and IFN-γ–driven pathology at mucocutaneous barriers

Tags:

Previous Article

Astrocytes are critical for fear memory

Next Article

Controlling mucocutaneous barriers by cytokines

Related Posts

Large-scale experimental assessment of variant effects on the structure and function of the citrate transporter SLC13A5

Large-scale experimental assessment of variant effects ...

 63

Cardiometabolic benefits of a non-industrialized- type diet are linked to gut microbiome modulation are linked to gut microbiome modulation

Cardiometabolic benefits of a non-industrialized- type ...

 120

Long-lived cellular molecules in the brain

Long-lived cellular molecules in the brain

 114